BPC 157 Cost: What You Need to Know The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Banned: Key Facts on the Latest FDA Decision Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand How did BPC 157 become the wellness industry's star peptide?